HRT vs. supplements
This article was originally published in The Tan Sheet
Executive Summary
Dietary Supplement Education Alliance is spending "in the five figures" to develop video news release (VNR) promoting supplement ingredients as alternatives to hormone replacement therapy for menopausal symptoms. Slated for release in early to mid August, the VNR will be accessible by every TV station in U.S. for possible inclusion in local news health segments. Two- to three-minute feature will include interviews with two Los Angeles-based doctors. Supplement marketers also are stepping up PR efforts following studies raising concerns about safety of long-term HRT use. GlaxoSmithKline (Remifemin) reps are now calling on family practitioners as well as OB/GYNs. Novogen is alerting independent pharmacists about safety, efficacy of its Promensil supplement, while Rexall (Sundown Menopause Support) is planning additional in-store promotions that may reference articles on HRT studies...
You may also be interested in...
Menopause remedy sales
Drugstore.com sales of supplements for menopause symptoms during third week of July jumped 47% over average weekly sales for the year, company says in first edition of the Health & Beauty Index. Increase followed release of Women's Health Initiative findings questioning safety of hormone replacement therapies, and supplement makers have since stepped up PR efforts touting their products as HRT alternatives (1"The Tan Sheet" July 29, 2002, In Brief). July sales on drugstore.com of GSK's Remifemin jumped 46% from June levels; other top-selling brands included J&J Personal Products' Healthy Woman, Pharmavite's Nature's Resource Soy Balance. E-tailer's new monthly index measures U.S. population trends, attitudes through health and wellness purchases...
Pharmaton Repackages Supplement Line; Launches Women’s Health Product
Pharmaton Natural Health Products is unifying its brands with revamped packaging that features a Pharmaton seal and product-specific icons
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.